FDA Inspection 1093466 — Quest Diagnostics
The FDA completed an inspection of Quest Diagnostics on May 23, 2019 in Lenexa, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- May 23, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lenexa, KS (United States)
Additional Details
Clinical BA/BE